Literature DB >> 26622464

Cutaneous Rosai-Dorfman disease in a middle-aged man: A case report.

Min Yang1, Jianmin Chang1.   

Abstract

The present study describes a case of cutaneous Rosai-Dorfman disease (CRDD). The clinical manifestations and therapeutic options of CRDD vary, and the etiology of the disease is still unknown. The clinical manifestations include single or multiple yellow-red to brown or purple papules, nodules and/or plaques, with the face being the most frequently affected site. A 52-year-old man presented with an 8-month history of multiple lesions on his face. Physical examination revealed a number of yellow-red papules and nodules, the majority of which had coalesced into plaques. The histological finding from a red papule showed a dense, dermal infiltrate, which was predominantly composed of large histiocytes, strongly positive for S-100 and cluster of differentiation (CD)68 but negative for CD1a, mixed with aggregates of lymphocytes and scattered plasma cells and eosinophils. The patient showed only a marginal improvement with a month of oral, low-dose prednisone.

Entities:  

Keywords:  Rosai-Dorfman disease; cutaneous

Year:  2015        PMID: 26622464      PMCID: PMC4533137          DOI: 10.3892/etm.2015.2580

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  17 in total

Review 1.  Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.

Authors:  J-W Tjiu; C-H Hsiao; T-F Tsai
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

2.  Cutaneous rosai-dorfman disease persisting after surgical excision: report of a case treated with acitretin.

Authors:  Katherine Fening; Mark Bechtel; Sara Peters; Matthew Zirwas; Kamruz Darabi
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

3.  Cutaneous Rosai-Dorfman disease following pneumococcal vaccination.

Authors:  Anastasia V Bassis; Janet A Fairley; Richard T Ameln; Brian L Swick
Journal:  J Am Acad Dermatol       Date:  2011-10       Impact factor: 11.527

4.  Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease.

Authors:  H S Chang; S-J Son; K H Cho; J H Lee
Journal:  Clin Exp Dermatol       Date:  2011-06       Impact factor: 3.470

5.  Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.

Authors:  Marion Nadal; Thibault Kervarrec; Marie-Christine Machet; Tony Petrella; Laurent Machet
Journal:  Acta Derm Venereol       Date:  2015-07       Impact factor: 4.437

6.  Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.

Authors:  Natalie Z Sun; Jessica Galvin; Kevin D Cooper
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

7.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

8.  A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy.

Authors:  Carl Gebhardt; Marco Averbeck; Uwe Paasch; Selma Ugurel; Hjalmar Kurzen; Patrick Stumpp; Jan C Simon; Regina Treudler
Journal:  Arch Dermatol       Date:  2009-05

9.  Cutaneous rosai-dorfman disease is a distinct clinical entity.

Authors:  Thomas Brenn; Eduardo Calonje; Scott R Granter; Niamh Leonard; Wayne Grayson; Christopher D M Fletcher; Phillip H McKee
Journal:  Am J Dermatopathol       Date:  2002-10       Impact factor: 1.533

10.  Extranodal rosai-dorfman disease with cutaneous and periodontal involvement: a rare presentation.

Authors:  M J Molina-Garrido; C Guillén-Ponce
Journal:  Case Rep Oncol       Date:  2011-02-16
View more
  1 in total

1.  Rosai-Dorfman Disease: Self-Resolving Unilateral Lymphadenopathy and a Brief Review of Literature.

Authors:  Joshua Feriante; Richard T Lee
Journal:  Case Rep Oncol Med       Date:  2018-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.